AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2011
Mar 14, 2011
31982_dirs_2011-03-14_f3428e9a-493c-4cfb-952a-f824f8aaf2a8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2011-03-10
Reporting Person: Glenn Gregory M (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-10 | Options-right to buy | $2.50 | A | 64000 | Acquired | 2021-03-10 | Common Stock (64000) | Direct |
Footnotes
F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.